The two FDA pilot programs—Real-Time Oncology Review and Assessment Aid sped up the processing of Novartis's supplemental new drug applications for Kisqali (ribociclib), said Samit Hirawat, executive vice president and head of Global Oncology at Novartis.
After achieving complete regression in several patients with different solid tumor types, Steven Rosenberg is eyeing the biggest prize imaginable—advancing the therapies he has championed for over four decades into the clinic as treatments for commonly occurring cancers.
In 2010, Otis Brawley and I were in the midst of writing a book about the state of cancer care in America.
I have been following Vinay Prasad's work for several years, agreeing with some of what he said, but never quite finding time to look carefully at his argumentation.
The practice-changing TAILORx trial was brought to you by publicly funded cancer clinical trials system, pointing to its continuing relevance, said Jeff Abrams, NCI acting director for clinical research and associate director of the Cancer Therapy Evaluation Program.
Patients who come to the American University of Beirut Medical Center and the Children's Cancer Center of Lebanon now have the same chances of cure, thanks to systematic program building over the years, said Raya Saab, acting director of the Children's Cancer Institute, and director of the Pediatric Cancer Research Program at the American University of Beirut Medical Center.
St. Jude Global will spend $100 million to improve care for kids with cancer and catastrophic blood disorders in low to middle-income countries, including those in the midst of conflicts, said Carlos Rodriguez-Galindo, executive vice president, chair of the Department of Global Pediatric Medicine, and director of St. Jude Global at St. Jude Children's Research Hospital.
After six months of listening and observing the functioning of MD Anderson Cancer Center, Peter Pisters announced changes in the cancer center's organizational chart.
There are a lot of gynecologists who are not gynecologic oncologists who live in rural areas, who don’t have access to oncologists, or who just have big egos, who will operate on patients with known premalignant disease or early stage cancer—regardless of the fact that they know that it is cancer.
Yale’s Desai: Gynecologists must preoperatively workup and discuss the risks, benefits, alternatives
We hope that our study increases the awareness and discussion of occult cancer risk in the thousands of women undergoing hysterectomy and myomectomy annually. Morcellation of a specimen allows for the dissemination of cancer, having an informed conversation with patients preoperatively is essential to this process.